Please login to the form below

Not currently logged in
Email:
Password:

Tofersen

This page shows the latest Tofersen news and features for those working in and with pharma, biotech and healthcare.

Biogen’s R&D chief Ehlers heads for the exit

Biogen’s R&D chief Ehlers heads for the exit

There’s still plenty in the neuroscience pipeline however, including  tofersen for amyotrophic lateral sclerosis (ALS) which stems from an alliance with antisense specialist Ionis and is due for a phase

Latest news

  • Biogen’s tofersen shows promise in slowing down ALS Biogen’s tofersen shows promise in slowing down ALS

    Hope for subset of patients with wasting disease. Biogen has revealed promising preliminary data for tofersen, a potential treatment for the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS). ... Tofersen is just one of seven candidates

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics